Quest Diagnostics Operating Income 2010-2024 | DGX

Quest Diagnostics annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Quest Diagnostics operating income for the quarter ending September 30, 2024 was $0.330B, a 3.51% decline year-over-year.
  • Quest Diagnostics operating income for the twelve months ending September 30, 2024 was $1.252B, a 10.8% increase year-over-year.
  • Quest Diagnostics annual operating income for 2023 was $1.262B, a 11.62% decline from 2022.
  • Quest Diagnostics annual operating income for 2022 was $1.428B, a 40.03% decline from 2021.
  • Quest Diagnostics annual operating income for 2021 was $2.381B, a 20.8% increase from 2020.
Quest Diagnostics Annual Operating Income
(Millions of US $)
2023 $1,262
2022 $1,428
2021 $2,381
2020 $1,971
2019 $1,231
2018 $1,101
2017 $1,165
2016 $1,277
2015 $1,399
2014 $983
2013 $1,475
2012 $1,201
2011 $987
2010 $1,284
2009 $1,359
Quest Diagnostics Quarterly Operating Income
(Millions of US $)
2024-09-30 $330
2024-06-30 $355
2024-03-31 $300
2023-12-31 $267
2023-09-30 $342
2023-06-30 $348
2023-03-31 $305
2022-12-31 $135
2022-09-30 $392
2022-06-30 $388
2022-03-31 $513
2021-12-31 $536
2021-09-30 $652
2021-06-30 $533
2021-03-31 $660
2020-12-31 $795
2020-09-30 $718
2020-06-30 $283
2020-03-31 $175
2019-12-31 $363
2019-09-30 $313
2019-06-30 $307
2019-03-31 $248
2018-12-31 $220
2018-09-30 $304
2018-06-30 $305
2018-03-31 $272
2017-12-31 $269
2017-09-30 $298
2017-06-30 $319
2017-03-31 $279
2016-12-31 $276
2016-09-30 $322
2016-06-30 $422
2016-03-31 $257
2015-12-31 $239
2015-09-30 $631
2015-06-30 $301
2015-03-31 $228
2014-12-31 $257
2014-09-30 $256
2014-06-30 $262
2014-03-31 $208
2013-12-31 $270
2013-09-30 $689
2013-06-30 $289
2013-03-31 $227
2012-12-31 $265
2012-09-30 $305
2012-06-30 $333
2012-03-31 $298
2011-12-31 $317
2011-09-30 $322
2011-06-30 $317
2011-03-31 $31
2010-12-31 $282
2010-09-30 $337
2010-06-30 $366
2010-03-31 $299
2009-12-31 $330
2009-09-30 $348
2009-06-30 $359
2009-03-31 $321
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.988B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.458B 11.77
DaVita (DVA) United States $12.872B 16.65
Encompass Health (EHC) United States $9.984B 23.54
Chemed (CHE) United States $8.238B 25.32
Elanco Animal Health (ELAN) United States $6.580B 15.66
RadNet (RDNT) United States $5.911B 130.90
Option Care Health (OPCH) United States $3.713B 17.60
Amedisys (AMED) United States $2.948B 20.98
LifeStance Health (LFST) United States $2.770B 0.00
Astrana Health (ASTH) United States $2.302B 31.49
Addus HomeCare (ADUS) United States $2.180B 25.57
U.S Physical Therapy (USPH) United States $1.368B 35.96
Aveanna Healthcare Holdings (AVAH) United States $1.121B 0.00
Pennant (PNTG) United States $1.093B 44.18
Atai Life Sciences (ATAI) Germany $0.290B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.015B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.008B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00